Inflammatory pathway kinases and transcription factors

Inflammatory pathway kinases and transcription factors refers to a broad category of intracellular proteins that transmit signals from cell-surface receptors to the nucleus to initiate an immune response. This group includes several families of kinases, such as Janus kinases (JAKs), Mitogen-activated protein kinases (MAPKs), and IkappaB kinases (IKKs), which act as critical nodes in signaling cascades (Source: Nature Reviews Drug Discovery). These kinases activate downstream transcription factors, including Nuclear factor kappa-B (NF-kappaB) and Signal transducers and activators of transcription (STATs), which then bind to specific DNA sequences to promote the expression of inflammatory cytokines and enzymes (Source: Journal of Immunology). Therapeutic targeting of these molecules is a well-established strategy for managing autoimmune and inflammatory diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease (Source: StatPearls). However, because these pathways are also vital for normal immune surveillance and hematopoiesis, their pharmacological inhibition carries risks of serious infections, hematologic abnormalities, and potential malignancies (Source: FDA).

Other names

Inflammatory signaling proteinsPro-inflammatory signaling cascade proteinsInflammatory signaling molecules

Inhibition of kinase-mediated phosphorylation cascades or modulation of transcription factor-driven gene expression to reduce the synthesis of pro-inflammatory cytokines and mediators.